Jennison Associates »

Aeglea Biotherapeutics shares owned by Jennison Associates

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Jennison Associates from 13F filings

Historical chart of Jennison Associates investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Jennison Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Jennison Associates

Quarter filed Position value Share count Share price at filing
2026-06-30 $27M 303k 88.78

More positions owned by Jennison Associates

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Tesla Motors (TSLA)
Crowdstrike Hldgs Cl A (CRWD)
Mastercard Incorporated Cl A (MA)

View all positions for Jennison Associates

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics